1 results match your criteria: "Spain. aromera@bellvitgehospital.cat[Affiliation]"
Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
Ann Vasc Surg
July 2010
Vascular Surgery Service, Hospital Universitari de Bellvitge, LHospitalet de Llobregat, Barcelona, Spain.
Background: We evaluated whether the incidence of recurrent venous thromboembolic events (VTEs) during and after therapy differs for patients treated with full or reduced doses of low-molecular-weight heparin (LMWH) used long term compared with vitamin K antagonists (VKAs).
Methods: We identified randomized studies of long-term treatment with LMWH or VKA by searching MEDLINE, EMBASE, BIOSIS, and PASCAL. Seventeen studies were included, with 4,002 patients.